Investors in Technology

Startupbootcamp Scale San Francisco is an innovation program for post-revenue technology startups from all over the globe. Startupbootcamp is crucial for investors because it has shown us how to decipher the entrepreneurial code, leading to a reduction in startup failures across their portfolio. Essentially, Startupbootcamp has crafted a process that achieves significant outcomes.

Yttrium is a growth equity investment firm specializing in B2B technology companies, partnering with management teams to scale their businesses globally. With over €750 million in assets under management, they focus on providing targeted, high-impact support for growth-stage investments. Yttrium operates from offices in Frankfurt, London, and Munich, backing companies to become global leaders in their sectors.

StartUp42 is a 4-month startup accelerator aimed at helping early-stage technology startups. Su42 is a non-profit accelerator designed by EPITA to offer hacker teams with a good idea the skills and opportunities they need to become startup founders. Twice a year, 7 new startups are accelerated by SU42 during a 4-month program.

Incubator providing experience, time and tech know-how to help and advice early stage start ups. An active Danish tech startup incubator providing capital, experience, and expertise. We have a combined 45+ years of experience within scalable B2B sales, .Net development, Cloud based business and development behind us.

Startfeld is a non-profit association with a philanthropic goal setting to support start-ups and innovation in the St.GallenBodenseeArea. Startfeld - Startup support of the Switzerland Innovation Parc East- is a non-profit association with a philanthropic goal setting to support startups and innovation in the Eastern Part of Switzerland. The network for innovations and start-ups was founded by the University of St.Gallen, FHS St.Gallen University of Applied Sciences, the Empa, the city of St.Gallen, the St.Galler Kantonalbank (SGKB) and Swisscom.

Overkill Ventures invests in pre-seed stage startups and helps them get to product-market fit. Overkill Ventures is a Nordics based angel fund that invests in pre-seed b2b tech startups across CEE and Nordics. We invest as early as angel investors do, however, have the resources, know-how and network to help startups get to product-market fit and scale from there.

The first dedicated cybersecurity incubator in the CEE region. OXO Cybersecurity Lab is a separate incubator of OXO Labs created exclusively to support cybersecurity innovation. The incubator involves a large number of industry specialists as team members as well as program mentors who can cover all critical aspects of the field.

Photon Delta is an industry accelerator for integrated photonics. PhotonDelta builds an ecosystem of organizations that is able to design, develop and manufacture world-class innovative solutions based on integrated photonic technology. PhotonDelta actively supports its partners with coaching, funding and access to market.

BVP is a venture firm celebrating 20 years in business, having evolved from a boutique corporate finance advisory into a multi-asset investment platform. Specializing in early and growth stage investments, BVP focuses on health, climate, mobility, and technology, backing ambitious entrepreneurs and tailoring solutions to the unique needs of their companies. Guided by principles of transparency, sustainability, and resilience, BVP leverages its deep market insight and two decades of experience to provide flexible investment strategies, including both debt and equity, to support the growth of impactful businesses.

Seroba is a leading European life sciences venture capital firm, dedicated to creating value by supporting innovative biotech and medtech companies. With a focus on breakthrough technologies, Seroba has backed significant advancements such as Shorla Oncology's FDA-approved TEPYLUTE, a ready-to-dilute formulation for treating breast and ovarian cancer. Based in Dublin, Seroba leverages deep industry expertise to help entrepreneurs build world-class businesses, fostering extraordinary scientific innovations.

"Our main goal is to help building new and developing already running innovation companies in order to expand market relations, build respectable homeland and foreign companies and maximize investors’ earnings. Before 2015 we were investing in real sector of economy, predominantly into oil and gas companies, thus we are confident in this sphere and what’s more important we have connections. Since 2015 our company is focused on innovation projects, which we help to increase capitalization and maximize profits. We neither play stock nor exchange markets. We invest in businesses, which we fully understand and for which we can offer something more than just money, but our knowledge, connections and experience. We are interested in microfinance (starting with $25000) for promising startups. That’s why we founded Capinvest 21 Seed Venture Fund I. We use economic-mathematical models and instruments of financial forecasting to choose which project is good for investing. We also always trust our guts while choosing a project. We choose promising projects, help them to run their companies and raise their capital. We come from Tyumen, Siberia, but we work around the world. In addition our company’s priority is to fund startups from CIS, MENA and Asia. We not only provide you with finance, we also help you to successfully run your projects. Capinvest 21 can be a profile investor for already existing companies, which long for further development and need funding."

Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by great entrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success.